Quick Answer
PROCEPT BioRobotics Corp reported Total Revenue of $308.05 million for the year ending 2025.
- PROCEPT BioRobotics Corp showed an increase of +37.2% in Total Revenue from 2024 to 2025.
- This data is from PROCEPT BioRobotics Corp's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $2.11 million | Q1 2021: $7.19 million | Q2 2021: $8.48 million | Q3 2021: $8.67 million | Q1 2022: $14.20 million | Q2 2022: $16.69 million | Q3 2022: $20.35 million | Q1 2023: $24.40 million | Q2 2023: $33.10 million | Q3 2023: $35.10 million | Q1 2024: $44.54 million | Q2 2024: $53.35 million | Q3 2024: $58.37 million | Q1 2025: $69.16 million | Q2 2025: $79.18 million | Q3 2025: $83.33 million.
- Over the full 6 years of available data (2020 to 2025), PROCEPT BioRobotics Corp's Total Revenue has grown by 3,891.9%.
- Historical annual values: Fiscal year 2025: $308.05 million | Fiscal year 2024: $224.50 million | Fiscal year 2023: $136.19 million | Fiscal year 2022: $75.01 million | Fiscal year 2021: $34.47 million | Fiscal year 2020: $7.72 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: